Previous studies reported that METTL3 plays an oncogenic role in acute myeloid leukaemia through diverse downstream targets [43], whereas other studies suggested that either increased or decreased METTL3 expression could promote the self-renewal and tumorigenicity of glioma stem-like cells, respectively [42, 44]. The gene discussed is METTL3; the disease is central nervous system cancer.